RAUL
ORTIZ DE LEJARAZU LEONARDO
Forscher in der Zeit 1983-2019
Hospital Universitario La Fe
Valencia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (16)
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2018
-
Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: A nationwide proficiency study
Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 3, pp. 692-697
2017
-
Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
-
HIV-2 viral tropism influences CD4+ T cell count regardless of viral load
Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194
-
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Journal of Clinical Virology
2013
-
IgM levels in plasma predict outcome in severe pandemic influenza
Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567
2012
-
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection
PLoS ONE, Vol. 7, Núm. 6
2011
2010
-
Host adaptive immunity deficiency in severe pandemic influenza
Critical Care, Vol. 14, Núm. 5
-
Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain
Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206
2009
-
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Critical Care, Vol. 13, Núm. 6